ethyl 2-(5-benzylthio-2-nitrophenoxy)acetate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl 2-(5-benzylthio-2-nitrophenoxy)acetate
• 英文别名: ethyl 2-(5-benzylsulfanyl-2-nitrophenoxy)acetate
• 化学式: C₁₇H₁₇NO₅S
• 分子量: 347.392
• InChiKey: LKJUVKQPVZHWOJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  24
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  107
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2-(5-氟-2-硝基苯氧基)乙酸乙酯 、 苄硫醇 在 盐酸 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以68%的产率得到ethyl 2-(5-benzylthio-2-nitrophenoxy)acetate
  参考文献：
  名称：

  Substituted-optionally hydrogenated isoquinoline compounds,

  摘要：

  该发明涉及一种异环丙烯衍生物，其化学式为I，其中Ar.sup.1是可选择取代的苯基、萘基或9-或10-成员的双环杂环基；A.sup.1是直接连接到X.sup.1或(1-3C)烷基的链；X.sup.1是氧、硫、亚硫酰基、磺酰基或亚胺基；Ar.sup.2是可选择取代的5-成员杂环基；R.sup.1是(1-4C)烷基、(3-4C)烯基或(3-4C)炔基；而R.sup.2和R.sup.3共同形成一个化学式为--A.sup.2--X.sup.2--A.sup.3--的基团，该基团与A.sup.2和A.sup.3所连接的碳原子一起定义具有5到7个环原子的环，其中A.sup.2和A.sup.3各自是(1-3C)烷基，X.sup.2是氧、硫、亚硫酰基或磺酰基；或其药用可接受盐。该发明的化合物是5-脂氧合酶的抑制剂。

  公开号：

  US05217978A1

文献信息

• Substituted-optionally hydrogenated isoquinoline compounds,
  申请人：Imperial Chemical Industries PLC

  公开号：US05217978A1

  公开（公告）日：1993-06-08

  The invention concerns a heterocyclene derivative of the formula I ##STR1## wherein Ar.sup.1 is optionally substituted phenyl, naphthyl or a 9- or 10-membered bicyclic heterocyclic moiety; A.sup.1 is a direct link to X.sup.1 or (1-3C)alkylene; X.sup.1 is oxy, thio, sulphinyl, sulphonyl or imino; Ar.sup.2 is optionally substituted 5-membered heterocyclene moiety; R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 5 to 7 ring atoms, wherein each of A.sup.2 and A.sup.3 is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl or sulphonyl; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  该发明涉及一种异环丙烯衍生物，其化学式为I，其中Ar.sup.1是可选择取代的苯基、萘基或9-或10-成员的双环杂环基；A.sup.1是直接连接到X.sup.1或(1-3C)烷基的链；X.sup.1是氧、硫、亚硫酰基、磺酰基或亚胺基；Ar.sup.2是可选择取代的5-成员杂环基；R.sup.1是(1-4C)烷基、(3-4C)烯基或(3-4C)炔基；而R.sup.2和R.sup.3共同形成一个化学式为--A.sup.2--X.sup.2--A.sup.3--的基团，该基团与A.sup.2和A.sup.3所连接的碳原子一起定义具有5到7个环原子的环，其中A.sup.2和A.sup.3各自是(1-3C)烷基，X.sup.2是氧、硫、亚硫酰基或磺酰基；或其药用可接受盐。该发明的化合物是5-脂氧合酶的抑制剂。
• Heterocyclene derivatives
  申请人：Imperial Chemical Industries PLC

  公开号：US05484805A1

  公开（公告）日：1996-01-16

  The invention concerns a heterocyclene derivative of the formula I ##STR1## wherein Ar.sup.1 is optionally substituted phenyl, naphthyl or a 9- or 10-membered bicyclic heterocyclic moiety; A.sup.1 is a direct link to X.sup.1 or (1-3C)alkylene; X.sup.1 is oxy, thio, sulphinyl, sulphonyl or imino; Ar.sup.2 is optionally substituted 5-membered heterocyclene moiety; R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sub.2 --A.sup.3 -- which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 5 to 7 ring atoms, wherein each of A.sup.2 and A.sup.3 is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl or sulphonyl; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  本发明涉及公式I的杂环衍生物，其中Ar.sup.1是可选取代的苯基、萘基或9-或10-环杂双环杂环基；A.sup.1是直接连接到X.sup.1或(1-3C)烷基；X.sup.1是氧、硫、亚硫酰基、磺酰基或亚胺基；Ar.sup.2是可选取代的5-环杂杂环基；R.sup.1是(1-4C)烷基、(3-4C)烯基或(3-4C)炔基；R.sup.2和R.sup.3一起形成公式--A.sup.2--X.sub.2--A.sup.3--的基团，其中，与A.sup.2和A.sup.3连接的碳原子一起定义一个具有5至7个环原子的环，其中A.sup.2和A.sup.3各自是(1-3C)烷基，X.sup.2是氧、硫、亚硫酰基或磺酰基；或其药学上可接受的盐。本发明化合物是5-脂氧合酶酶抑制剂。
• Benzothiaziny derivatives
  申请人：Imperial Chemical Industries PLC

  公开号：US05321025A1

  公开（公告）日：1994-06-14

  The invention concerns a bicyclic heterocyclic compound of the formula I ##STR1## wherein Q is an optionally substituted 10-membered bicyclic heterocyclic moiety containing 1 or 2 N's and a further O or S heteroatom; A.sup.1 is a direct link to X.sup.1 or (1-3C)alkylene; X.sup.1 is oxy, thio, sulphinyl, sulphonyl or imino; Ar is optionally substituted phenylene or pyridylene; R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; and R.sup.2 and R.sup.3 together form a group of the formula -A.sup.2 -X.sup.2 -A.sup.3 - which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 5 to 7 ring atoms, wherein each of A.sup.2 and A.sup.3 is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl or sulphonyl; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  本发明涉及一种公式I的双环杂环化合物：##STR1## 其中Q是可选取的含有1或2个N和进一步的O或S杂原子的10元双环杂环基团；A.sup.1是直接连接到X.sup.1或(1-3C)烷基的链；X.sup.1是氧、硫、亚砜、磺酰或亚胺基；Ar是可选取的取代苯基或吡啶基；R.sup.1是(1-4C)烷基、(3-4C)烯基或(3-4C)炔基；而R.sup.2和R.sup.3共同形成一个公式-A.sup.2-X.sup.2-A.sup.3-的基团，其中，与A.sup.2和A.sup.3相连的碳原子一起定义了一个具有5到7个环原子的环，其中，A.sup.2和A.sup.3中的每一个都是(1-3C)烷基链，而X.sup.2是氧、硫、亚砜或磺酰；或其药学上可接受的盐。本发明的化合物是5-脂氧合酶酶的抑制剂。
• Pyridooxazinyl or pyridothiazinyl as inhibitors of leukotrienes
  申请人：Zeneca Limited

  公开号：US05373007A1

  公开（公告）日：1994-12-13

  The invention concerns a bicyclic heterocyclic compound of the formula I ##STR1## wherein Q is an optionally substituted 10-membered bicyclic heterocyclic moiety containing 1 or 2 N's and a further O or S heteroatom; A.sup.1 is a direct link to X.sup.1 or (1-3C)alkylene; X.sup.1 is oxy, thio, sulphinyl, sulphonyl or imino; Ar is optionally substituted phenylene or pyridylene; R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 5 to 7 ring atoms, wherein each of A.sup.2 and A.sup.3 is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl or sulphonyl; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  本发明涉及一种公式I的双环杂环化合物：##STR1## 其中，Q是含有1或2个N和另一个O或S杂原子的可选取代的10元双环杂环基；A.sup.1是直接连接到X.sup.1或(1-3C)烷基；X.sup.1是氧、硫、亚磺酰基、磺酰基或亚胺基；Ar是可选取代的苯基或吡啶基；R.sup.1是(1-4C)烷基、(3-4C)烯基或(3-4C)炔基；R.sup.2和R.sup.3共同形成一个公式--A.sup.2--X.sup.2--A.sup.3--的基团，其中A.sup.2和A.sup.3均为(1-3C)烷基，X.sup.2为氧、硫、亚磺酰基或磺酰基；或其药学上可接受的盐。本发明的化合物是5-脂氧合酶酶的抑制剂。
• Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase
  申请人：ZENECA LIMITED

  公开号：EP0462813A2

  公开（公告）日：1991-12-27

  The invention concerns a bicyclic heterocyclic compound of the formula I, or a pharmaceutically-acceptable salt thereof. The invention concerns also processes for the manufacture of a bibyclic heterocyclic compound of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said compound. Also included in the invention is a method of treating various inflammatory or allergic diseases using a bibyclic heterocyclic compound of the formula I, or a pharmaceutically-acceptable salt thereof, and the use of such a compound in the production of a new medicament for such use.

  本发明涉及一种式 I 的双环杂环化合物或其药学上可接受的盐。本发明还涉及式 I 双环杂环化合物或其药学上可接受的盐的生产工艺，以及含有所述化合物的药物组合物。本发明还包括使用式 I 的双环杂环化合物或其药学上可接受的盐治疗各种炎症或过敏性疾病的方法，以及使用这种化合物生产用于这种用途的新药物。